Literature DB >> 21718871

Aortic root vasculitis associated with Cogan's syndrome.

Hrvoje Gasparovic1, Zeljko Djuric, Dubravka Bosnic, Mate Petricevic, Margita Brida, Snjezana Dotlic, Bojan Biocina.   

Abstract

Cogan's syndrome is characterized by nonsyphilitic interstitial keratitis and an audiovestibular disorder resembling Meniere disease. We report a patient with progressive congestive heart failure due to massive aortic and mitral insufficiency coupled with aortitis leading to an ascending aortic aneurysm. The patient underwent successful aortic root replacement and mitral valve repair.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21718871     DOI: 10.1016/j.athoracsur.2010.12.068

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Mitral valve thickening in Cogan's syndrome.

Authors:  Katsuhiro Koyama; Masao Daimon; Hiroaki Semba; Jack H Wang; Kansei Uno; Takayuki Kawata; Tomoko Nakao; Koichi Kimura; Issei Komuro
Journal:  J Echocardiogr       Date:  2014-07-24

Review 2.  Cogan's syndrome and other ocular vasculitides.

Authors:  Gabriela M Espinoza; Angela Prost
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

3.  Aortic aneurysm associated with rheumatoid arthritis: a population-based cross-sectional study.

Authors:  Ora Shovman; Shmuel Tiosano; Doron Comaneshter; Arnon D Cohen; Howard Amital; Michael Sherf
Journal:  Clin Rheumatol       Date:  2016-08-09       Impact factor: 2.980

Review 4.  Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.

Authors:  Durga Prasanna Misra; Sajjan N Shenoy
Journal:  Rheumatol Int       Date:  2016-02-17       Impact factor: 2.631

Review 5.  Autoimmune Inner Ear Disease: Immune Biomarkers, Audiovestibular Aspects, and Therapeutic Modalities of Cogan's Syndrome.

Authors:  Oded Shamriz; Yuval Tal; Menachem Gross
Journal:  J Immunol Res       Date:  2018-04-23       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.